The Company assumes no 50mg generic ultram obligation to update its forward-looking statements to reflect new information and developments. Although we believe that these statements 50mg generic ultram are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements are merely the Company’s current predictions of future events. The company markets an extensive line of generic products through three business units, Mylan Pharmaceuticals Inc. , Mylan Technologies Inc. , and UDL Laboratories, Inc. Under the terms of the agreement, Able Labs will manufacture and supply the product exclusively to IVAX under their label and IVAX will exclusively sell Able Labs’ manufactured product. The approval of Tramadol HCl, 50mg tablets is 50mg generic ultram the 8th approval received by Eon Labs in 2002. Ultram’s 50mg generic ultram 2001 sales reached $650 million. United Research Laboratories/Mutual Pharmaceutical Co. Tramadol 50 mg tablets are available in 100-, 500- and 1,000-count bottles and are indicated for the management of moderate to moderately severe pain 50mg generic ultram in adults. (1) Ultram is a registered trademark of Ortho-McNeil Pharmaceutical, Inc. Food and 50mg generic ultram drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Tablets, 50mg. Copies of this and other news releases may be obtained free of charge from IVAX’ web site at http://www. Mutual also received preliminary approval for tramadol 50 mg tablets, the generic version of the pain killer Ultram. Business Editors & Medical Writers Eon 50mg generic ultram labs, Inc. Mylan’s Tramadol product 50mg generic ultram is the generic version of R. Shareholders and prospective investors can register to automatically receive the company’s press releases via email at www. Com/ComNewsv2. (Nasdaq: TEVA) announced today that the U. The FDA refers 50mg generic ultram to the United States Food and Drug Administration. Johnson’s Ultram(R), is approximately $550 50mg generic ultram million according to the IMS Data. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks and uncertainties that could cause the Company’s future results, 50mg generic ultram performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management.